High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in mice

Journal of Gastroenterology

Volumn 39, Issue 4, 2004, Pages 346-354

  Nakamura, Kimihide ^a   Yokohama, Shiro ^a   Yoneda, Masashi ^b   Okamoto, Satoshi ^a   Tamaki, Yohosui ^a   Ito, Taku ^a   Okada, Mitsuyoshi ^a   Aso, Kazunobu ^a   Makino, Isao ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemokine; Concanavalin A; Cytokine; Hyaluronan; T cell mediated liver injury

Indexed keywords

CONCANAVALIN A; CYTOKINE; GALACTOSAMINE; GAMMA INTERFERON; HYALURONIC ACID; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; LIVER INJURY; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CONCANAVALIN A; CYTOKINES; FEMALE; GALACTOSAMINE; HYALURONIC ACID; INFUSIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; LIVER DISEASES; MALE; MICE; MODELS, ANIMAL; MOLECULAR WEIGHT; T-LYMPHOCYTES;

EID: 2542448320     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-003-1301-x     Document Type: Article

References (44)

1. Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992:6:2397-404.
2. Poupon RE, Balkau B, Guéchot J, Heintzmann F. Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue. Hepatology 1994;19:635-40.
3. Körner T, Kropf J, Gressner M. Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. J Hepatol 1996;25:684-8.
4. Guéchot J, Serfaty L, Bonnand A-M, Chazouilléres O, Poupon RE, Poupon R. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol 2000;32:447-52.
5. Sconocchia G, Titus JA, Segal DM. CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells. J Immunol 1994; 153:5473-81.
6. Degrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997;278:672-5.
7. Maiti A, Maki G, Johnson P. TNF-α induction of CD44-mediated leukocyte adhesion by sulfation. Science 1998;282:941-3.
8. Siegelman MH, DeGrendele HC, Estess P. Activation and interaction of CD44 and hyaluronan. J Leukoc Biol 1999;66:315-21.
9. Levesque MC, Haynes BF. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-γ. J Immunol 2001;166:188-96.
10. McKee CM, Penno MB, Cowman M, Burdick MD, Stricter RM, Bao C, et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages; the role of HA size and CD44. J Clin Invest 1996;98:2403-13.
11. McKee CM, Lowenstein CJ, Horton MR, Wu J, Bao C, Chin BY, et al. Hyaluronan fragments induce nitric-oxide synthase in marine macrophages through a nuclear factor kB-dependent mechanism. J Biol Chem 1997;272:8013-8.
12. Hodge-Dufour J, Noble PW, Horton MR, Bao C, Wysoka M, Burdic MD, et al. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol 1997;159:2492-500.
13. Horton MR, McKee CM, Bao C, Liao F, Farber JM, Hodge-Dufour J, et al. Hyaluronan fragments synergize with interferon- ́induce the C-X-C chemokines Mig and interferon-inducible protein-10 in mouse macrophages. J Biol Chem 1998;73:35088-94.
14. Ariel A, Lider O, Brill A, Cahalon L, Savion N, Varon D, et al. Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators. Immunology 2000:100:345-51.
15. Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM. Prehm P, et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000;165:1863-70.
16. Termeer CC, Bendix F, Sleeman J, Fieber C, Voith U, Ahrens T. et al. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002;195:99-111.
17. Holmes MWA, Bayliss MT, Muir H. Hyaluronic acid in human articular cartilage; age-related changes in content and size. Biochem J 1988;250:435-41.
18. Neumann A, Schinzel R, Palm D, Riederer P, Münch G. High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kB activation and cytokine expression. FEBS Lett 1999;453:283-7.
19. Asari A, Miyauchi S, Matsuzaka S, Ito T, Kominami E, Uchiyama Y. Molecular weight-dependent effects of hyaluronate on the arthritic synovium. Arch Histol Cytol 1998;61:125-35.
20. Gotoh S, Onaya J, Abe M, Miyazaki K, Hamai A, Horie K, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis 1993;52:817-22.
21. Polubinska A, Pawlaczyk K, Kuzlan-Pawlaczyk M, Wieczorowska-Tobis K, Chen C, Moberly JB, et al. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats. Kidney Int 2000;57:1182-9.
22. Brandt KD, Smith GN Jr, Simon LS. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis; what is the evidence? Arthritis Rheum 2000;43:1192-203.
23. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992;90:196-203.
24. Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994;179:1529-37.
25. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995;21:190-8.
26. Küsters S, Gantner F, Künstle G, Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996;111:462-71.
27. -/- mice: role for IFN-γ in activating apoptosis of hepatocytes. J Immunol 1997;159:1418-28.
28. Toyabe S, Seki S, Iiai T, Takeda K, Shirai K, Watanabe H, et al. Requirement of IL-4 and liver NK1 + T cells for concanavalin A-induced hepatic injury in mice. J Immunol 1997;159:1537-42.
29. Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F, et al. Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 2000;191:105-14.
30. Nakamura K, Okada M, Yoneda M, Takamoto S, Nakade Y, Tamori K, et al. Macrophage inflammatory protein-2 induced by TNF-α plays a pivotal role in concanavalin A-induced liver injury in mice. J Hepatol 2001;35:217-24.
31. Nakamura K, Ito T, Yoneda M, Takamoto S, Nakade Y, Okamoto S, et al. Antithrombin III prevents concanavalin A-induced liver injury through inhibition of macrophage inflammatory protein-2 release and production of prostacyclin in mice. J Hepatol 2002;36:766-73.
32. Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, et al. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 1996;23:506-14.
33. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and Kupffer cells. Hepatology 1998;27:507-12.
34. Deutschman CS, Haber BA, Andrejko K, Cressman DE, Harrison R, Elenko E, et al. Increased expression of cytokine-induced neutrophil chemoattractant in septic rat liver. Am J Physiol 1996;271:R593-600.
35. Hamada E, Nishida T, Uchiyama Y, Nakamura J, Isahara K, Kazuo H, et al. Activation of Kupffer cells and caspase-3 involved in rat hepatocyte apoptosis induced by endotoxin. J Hepatol 1999;30:807-18.
36. Nakayama M, Arai K, Hasegawa K, Sato K, Ohtsuka K, Watanabe H, et al. Adhesion molecules on intermediate TCR cells, hepatoprotective effects of hyaluronic acid on acute liver injury. Cell Immunol 1995;166:275-85.
37. Wolf D, Schümann J, Koeber K, Kimer AK, Vollmar AM, Sass G, et al. Low-molecular-weight hyaluronic acid induces nuclear factor-kB-dependent resistance against tumor necrosis factor α -mediated liver injury in mice. Hepatology 2001;34:535-47.
38. Takamoto S, Nakamura K, Yoneda M, Makino I. Gender differences in concanavalin A-induced liver injury and cytokine production in mice. Hepatol Res 2003;27:221-9.
39. Henderson EB, Grootveld M, Farrell A, Smith EC, Thompson PW, Blake DR. A pathological role for damaged hyaluronan in synovitis. Ann Rheum Dis 1991;50:196-200.
40. Mikecz K, Brennan FR, Kim JH, Glant TT. Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat Med 1995;1:558-63.
41. Rafi-Janajreh AQ, Chen D, Schmits R, Mak TW, Grayson RL, Sponenberg DP, et al. Evidence for the for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. J Immunol 1999;163:1619-27.
42. Blass SL, Puré E, Hunter CA. A role for CD44 in the production of IFN-γ and immunopathology during infection with Toxoplasma gondii. J Immunol 2001;166:5726-32.
43. Chen D, McKallip RJ, Zeytun A, Do Y, Lombard C, Robertson JL, et al. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death. J Immunol 2001;166:5889-97.
44. Arai K, Iiai T, Nakayama M, Hasegawa K, Sato K, Ohtsuka K, et al. Adhesion molecules on intermediate TCR cells. Immunology 1995;84:64-71.